https://tolmar.com/patient-assistance-programs-and-advocacy-resources/
Tolmar | Patient Assistance Programs and Advocacy Resources
Jun 6, 2024 - Tolmar is committed to making our therapies accessible. Learn about our copay support, benefit verification, and Patient Assistance Programs.
patient assistance programs
https://tolmar.com/technology-commercialization/
Technology & Commercialization | Tolmar
Sep 11, 2024 - At Tolmar, we fuel the research, ideation, and development of treatments and experiences that address the real needs of patients worldwide.
technology amptolmar
https://tolmar.com/working-at-tolmar/
Working at Tolmar | Join Us
Apr 30, 2025 - Tolmar fosters a culture of diversity, equity, and inclusion to encourage a safe and inviting work environment for all. Learn about our culture.
join usworkingtolmar
https://tolmar.com/manufacturing/
Tolmar | Hands-On Manufacturing Process
Sep 30, 2024 - At Tolmar, we take pride in our hands-on manufacturing process that sees ideas through to completion. See our process in motion.
manufacturing processtolmar
Sponsored https://www.fanvue.com/lina-rose
Lina Rose - Fanvue
Baddest bitch on Fanvue. You have no idea what you've gotten yourself into. Only enter if you can handle me...
https://tolmar.com/capabilities/
Tolmar Capabilities | Science-Driven and Patient Inspired
science driventolmarpatient
https://tolmar.com/treatments/
Tolmar | Proudly Delivering Life-Changing Treatments
delivering lifetolmarproudly
https://tolmar.com/research-development/
Research & Development | Tolmar
Sep 12, 2024 - Tolmar’s research and development enables product improvements by focusing on barriers to patient needs. Learn more about our process.
research amp development
https://tolmar.com/about-tolmar/
About Us | Tolmar
Apr 6, 2025 - At Tolmar, the combination of our passion, people, and expertise improve patient experiences in ways that really matter. Learn more.
ustolmar
https://www.prnewswire.com/news-releases/tolmar-announces-expanded-indication-for-rubraca-rucaparib-first-and-only-parp-inhibitor-to-outperform-docetaxel-in-a-head-to-head-phase-3-trial-302646925.html
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to...
/PRNewswire/ -- Tolmar, Inc. (Tolmar) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Rubraca®...
announces expandedtolmarfirst
Sponsored https://www.luvr.ai/
Luvr AI - Your AI girlfriend | AI Girlfriend Chat | AI Girlfriend Free
Fall in love with your personal AI Girlfriend on Luvr AI! Enjoy AI Girlfriend Chat and free features with fully uncensored character roleplay
https://tolmar.com/contact-us/
Contact Us | Tolmar
Oct 2, 2025 - The Tolmar team is ready to answer any of your questions. Simply reach out and one of our representatives will get in touch with you.
ustolmar
https://tolmar.com/
Tolmar | Daring to Solve Complex Problems
Feb 11, 2025 - At Tolmar, we’re dedicated to improving experiences and outcomes for patients and healthcare providers who care for them.
solve complex problemstolmar